Leukemia, Myeloid
Showing 1 - 25 of 6,879
Acute Myeloid Leukemia Trial in Antalya
Recruiting
- Acute Myeloid Leukemia
-
Antalya, TurkeyAntalya Training and Research Hospital
Jul 29, 2023
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Patients With Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia, Adult
-
Freiburg, CA, GermanyMedical Center- University of Freiburg
Aug 4, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 23, 2023
Acute Myeloid Leukemia Trial in Taipei
Enrolling by invitation
- Acute Myeloid Leukemia
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 9, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag Olamine
- (no location specified)
Jul 5, 2023
PET Tracer Based FDG Signal for Predicting Prognosis in Acute
Enrolling by invitation
- Acute Myeloid Leukemia
- No intervention
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Jinan University
Jun 22, 2023
Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)
Not yet recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaYuan Kong
Sep 4, 2023
Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +2 more
-
Suzhou, Jiangsu, ChinaQiu Huiying
Mar 28, 2023
GilteRInf 2022 Study (Gilteritinib Related Infections)
Active, not recruiting
- Acute Myeloid Leukemia
-
Roma, RM, ItalyMaria Ilaria Del Principe
Mar 17, 2023
Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- B7-H3 target, CAR gene modified gdT cell injection
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Feb 15, 2023
Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
Recruiting
- Leukemia, Myeloid, Acute
- Minimal Residual Disease
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital (NCCH)
Feb 2, 2023
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)
Recruiting
- Leukemia, Myeloid, Acute
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Dec 27, 2022
Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)
Recruiting
- Refractory/Relapse Acute Myeloid Leukemia
-
Kunming, Yunnan, ChinaDepartment of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023
Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)
Recruiting
- Acute Myeloid Leukemia
- CIML-NK Cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 4, 2023
Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 13, 2022
Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Miami, FloridaUniversity of Miami
Dec 22, 2022
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,
Active, not recruiting
- Acute Myeloid Leukemia
- +5 more
- Decitabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
AML Trial in Guanzhou (CLAG)
Not yet recruiting
- AML
- CLAG
-
Guanzhou, Guangdong, China
- +1 more
May 16, 2023
Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)
Not yet recruiting
- Acute Myeloid Leukemia
- High-Risk and Very High-Risk Myelodysplastic Syndromes
- (no location specified)
Jul 25, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022